Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial
Abstract Introduction and Aims Previous studies suggest cannabinoid agonist treatment is
effective in reducing cannabis use in dependent treatment seekers, however few studies
have reported on post-treatment outcomes. We examine cannabis use outcomes 12 weeks
after cessation of treatment from a randomised placebo-controlled trial of nabiximols for the
treatment of cannabis dependence. Method 128 participants received either nabiximols (n=
61) or placebo (n= 67) for 12 weeks, in combination with psychosocial interventions. Self …
effective in reducing cannabis use in dependent treatment seekers, however few studies
have reported on post-treatment outcomes. We examine cannabis use outcomes 12 weeks
after cessation of treatment from a randomised placebo-controlled trial of nabiximols for the
treatment of cannabis dependence. Method 128 participants received either nabiximols (n=
61) or placebo (n= 67) for 12 weeks, in combination with psychosocial interventions. Self …